| OR (95% CI) | ||||
---|---|---|---|---|---|
Q1 MedDQI score range: 3–5 | Q2 | Q3 | Q4 MedDQI score range: 8–11 | P for trend | |
Total | |||||
No. of cases/controls | 52/51 | 37/54 | 22/27 | 39/18 | Â |
Crude | 1 | 1.48 (0.84–2.63) | 1.25 (0.63–2.47) | 0.47 (0.23–0.92) | 0.012 |
Model 1 | 1 | 1.49 (0.84–2.65) | 1.25 (0.63–2.5) | 0.47 (0.24–0.93) | 0.012 |
Model 2 | 1 | 1.45 (0.79–2.65) | 1.19 (0.58–2.45) | 0.45 (0.21–0.94) | 0.022 |
Model 3 | 1 | 1.45 (0.79–2.65) | 1.45 (0.79–2.65) | 0.45 (0.21–0.94) | 0.02 |
Premenopause | |||||
No. of cases/controls | 32/30 | 21/33 | 14/20 | 21/13 | Â |
Crude | 1 | 1.67 (0.8–3.51) | 1.52 (0.65–3.54) | 0.66 (0.28–1.54) | 0.15 |
Model 1 | 1 | 1.69 (0.8–3.56) | 1.54 (0.66–3.62) | 0.67 (0.28–1.59) | 0.16 |
Model 2 | 1 | 2.07 (0.94–4.58) | 1.57 (0.63–3.91) | 0.72 (0.28–1.8) | 0.11 |
Model 3 | 1 | 2.06 (0.93–4.55) | 1.57 (0.63–3.93) | 0.73 (0.28–1.54) | 0.12 |
Postmenopause | |||||
No. of cases/controls | 20/21 | 16/21 | 8/7 | 18/5 | Â |
Crude | 1 | 1.69 (0.51–3.56) | 0.83 (0.25–2.72) | 0.26 (0.08–0.84) | 0.07 |
Model 1 | 1 | 1.33 (0.53–3.34) | 0.9 (0.27–2.99) | 0.24 (0.07–0.8) | 0.055 |
Model 2 | 1 | 1.22 (0.44–3.39) | 1.05 (0.27–4.04) | 0.23 (0.05–0.91) | 0.1 |
Model 3 | 1 | 1.23 (0.44–3.46) | 0.9 (0.25–3.88) | 0.18 (0.04–0.77) | 0.06 |